Breaking: nurse-led piercing hits 100+ studios $20M Series B led by VMG Partners Backed by Kevin Durant's Thirty Five Ventures Adverse reaction rate under 1% 550+ licensed nurse piercers on staff Reported $70M a year, $150M run-rate projected Breaking: nurse-led piercing hits 100+ studios $20M Series B led by VMG Partners Backed by Kevin Durant's Thirty Five Ventures Adverse reaction rate under 1% 550+ licensed nurse piercers on staff Reported $70M a year, $150M run-rate projected
Company Profile · Consumer Health

Rowan.

The brand that put a licensed nurse where the piercing gun used to be - and made safety the whole point.

100+Studios
550+Nurse piercers
<1%Adverse rate
$20MSeries B
Rowan ear piercing and jewelry
Rowan, photographed mid-ritual: the only earring counter staffed by people who took a licensing exam.
Who they are now

A clinic-grade idea hiding inside a jewelry counter.

Walk into a Rowan studio and the first thing you notice is what's missing. No spring-loaded gun. No teenager reading the instructions off a laminated card. Instead, a licensed nurse, a single-use needle, and a tray of nickel-free earrings. The ritual is the same one humans have performed for thousands of years. The standards are not.

Rowan runs more than 100 studios across the United States, staffs over 550 nurse piercers, and sells hypoallergenic jewelry both in person and online. It is, depending on who you ask, a healthcare company that happens to sell earrings or a jewelry brand that happens to employ nurses. The company would prefer you stop trying to choose.

Ear piercing is a powerful and symbolic milestone that deserves a safe and modernized approach for all - no matter one's age, gender, culture or financial status. - Louisa Serene Schneider, Founder & CEO
The problem she saw

The most common cosmetic procedure in the country had no rules.

Here is the uncomfortable truth Rowan was built on: getting your ears pierced is a minor medical event, and for decades it was handled like a vending-machine transaction. A piercing gun forces a blunt stud through cartilage and tissue, and the gun itself cannot be fully sterilized. The earring is the needle. The mall kiosk is the operating room. Nobody published their infection numbers because nobody was keeping any.

For most people this works out fine. For an unlucky minority it means infections, allergic reactions to cheap nickel, and a first piercing memory closer to a flinch than a celebration. The industry's answer had always been a shrug. Schneider thought the shrug was the opportunity.

1000s
Of years old, this ritual
~0
Published safety standards before
Nickel
The quiet culprit behind reactions
The piercing gun was the villain. A nurse and a single-use needle were the rewrite. - The thesis, in one sentence
The founder's bet

A Wall Street trader bet her career on earrings.

Louisa Serene Schneider had a perfectly respectable reason not to do this. She covered consumer and retail at JP Morgan, earned an MBA from Columbia, and went back to trade retail stocks at Morgan Stanley. She knew exactly how often new consumer brands fail. She left anyway.

Rowan started around 2017 in her attic, which is a wonderfully unglamorous origin for a company now valued in the tens of millions. The bet was almost contrarian in its modesty: that people would pay more, and travel further, for a piercing that was boring in all the right ways. No drama. No infection. No regret. Safety, it turns out, is a feature people will book an appointment for.

She traded retail stocks for a living, then decided the better trade was fixing the retail experience itself. - On leaving the trading desk
The milestones

From an attic to a hundred storefronts

2017

The attic years

Schneider, fresh off a trading desk, starts Rowan as a side project built on one idea: piercing should meet medical standards.

2019

Rowan launches

The nurse-led model goes public, pairing licensed nurses with hypoallergenic, nickel-free jewelry and aftercare.

2020

The Target experiment

Rowan tests shop-in-shop piercing inside hundreds of Target stores - a fast lesson in scale and brand control.

2021

$20M Series B

VMG Partners leads the round, joined by Kevin Durant's Thirty Five Ventures, Beechwood, Silas, Goldcrest and others.

2022

Goes it alone

Rowan exits Target to focus on company-owned studios, where it controls every part of the experience.

2025

100+ studios

Reported around $70M a year with a $150M run-rate projection, expanding across California and beyond.

The product

What you actually buy is trust, packaged as a piercing.

The service is the obvious part: a nurse pierces your ears, or your child's, with a sterile single-use needle in a clean studio. The less obvious part is everything Rowan built around it - hypoallergenic jewelry engineered for safe healing, an aftercare system informed by a medical advisory board, and an online shop for the people who came back to add a second, third, or seventh earring to the stack.

Nurse-led piercing

Licensed nurses, single-use needles, clinical hygiene - for first-timers, kids, and serial stackers alike.

Hypoallergenic jewelry

Nickel-free, medical-grade earrings designed to heal cleanly and stack endlessly.

E-commerce shop

A direct-to-consumer store so the relationship keeps going long after the appointment ends.

Aftercare & education

Guidance and products backed by a medical advisory board, because the piercing is only step one.

Most brands sell the earring. Rowan sells the hour you'll never have to regret. - On what the company is really selling
The proof

The footprint grew. The numbers followed.

Reported / projected figures · sources: CNBC, Modern Retail, Business Wire
$5M
Seed total
$20M
Series B
~$70M
Revenue '25
$150M
Run-rate proj.
Bars scaled for comparison. Funding and revenue are different things - shown together to trace one company's arc, not a balance sheet.
100+
Studios nationwide
550+
Licensed nurse piercers
<1%
Adverse outcome rate
390+
Employees
The mission

Two milestones in one: a safer piercing, and a better job.

Rowan's stated mission is to make ear piercing safe and celebratory for everyone, regardless of age, gender, culture, or budget. That's the customer-facing half. The other half is quieter and arguably more interesting: the company built a workforce of nurses doing meaningful, flexible work outside a hospital. Its Series B announcement framed expansion and nurse employment as the same goal, not competing ones.

It's a tidy bit of alignment. The thing that makes the service trustworthy - a real nurse - is also the thing that gives a nurse a different kind of career. Rowan didn't have to choose between mission and margin. It wired them together.

The same decision that makes the piercing safe also makes the job worth having. - On Rowan's double bottom line
Why it matters tomorrow

Walk back into that studio.

Return to the counter where we started. The gun is still gone. The nurse is still there. But now there's a category forming around the space Rowan opened - competitors borrowing the language of safety, malls courting the storefront, parents who would no longer dream of a piercing done any other way. That is what happens when a company names a problem nobody was naming: the standard moves, and then everyone pretends it was always there.

Rowan's harder test is ahead. Doubling a store count is expensive, and the trust that built the brand is fragile - it survives only as long as the adverse rate stays where it is. But the bet from the attic still holds. Make the boring, safe version of an old ritual, and people will travel for it, pay for it, and bring their kids. Rowan didn't reinvent ear piercing. It just refused to keep treating it like nothing.

Spread the word

Share Rowan

Watch & demo
Find Rowan

Sources & further reading